scispace - formally typeset
J

Jon Lindstrom

Researcher at University of Pennsylvania

Publications -  442
Citations -  50369

Jon Lindstrom is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Acetylcholine receptor & Nicotinic agonist. The author has an hindex of 108, co-authored 441 publications receiving 48999 citations. Previous affiliations of Jon Lindstrom include University of California, San Diego & University of California, Riverside.

Papers
More filters
Journal ArticleDOI

Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system.

TL;DR: In the present study, three different monoclonal antibodies raised against the α7 subunit were used to map its distribution throughout the central nervous system of the rat.
Journal ArticleDOI

Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies

TL;DR: MAbs have proven to be excellent probes for these proteins, and have been used to show that neuronal nicotinic AChRs of chickens, rats, and cattle are macromolecules approximately 10 S in size and composed of only 2 kinds of subunits: an ACh-binding subunit and a structural subunit.
Journal ArticleDOI

Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model

TL;DR: Peroxidase-conjugated α-bungarotoxin (P-BGT) was used for the ultrastructural localization of the acetylcholine receptor in end-plates in external intercostal muscles of four patients with myasthenia gravis, in forelimb digit extensor muscles of rats with advanced chronic experimental autoimmune myasthensia Gravis, and in suitable human and rat controls.
Journal ArticleDOI

Mutation Causing Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Alters Ca2+ Permeability, Conductance, and Gating of Human α4β2 Nicotinic Acetylcholine Receptors

TL;DR: The net effect of the mutation is to reduce AChR function, which could result in the hyperexcitability characteristic of epilepsy if the mutant AChRs were part of an inhibitory circuit, e.g., presynaptically regulating the release of GABA.
Journal ArticleDOI

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.

TL;DR: In the present study, acute EAMG, induced either by passive transfer of syngeneic antibodies or by active immmunization, was inhibited in rats depleted of complement by treatment with cobra venom factor (CoF), implying that redistribution, accelerated degradation, and impairment of the ionophore function of AChR, effects of antibodies described in vitro on extrajunctional A chR, do not play a significant role in vivo in impairing neuromuscular transmission in an